BG MEDICINE, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 40 rows, 40 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-07-16: Reporting owner Flagship Ventures 2007 General Partner LLC | Flagship Ventures Fund 2007, L.P.; Form 3; Security Series A Preferred Stock; Transaction Holding.
- 2015-07-14: Reporting owner NewcoGen Group, Inc. | Flagship Ventures Management, Inc. | AGTC Partners, L.P. | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | AGTC ADVISORS FUND LP | Applied Genomic Technology Capital Fund LP | AFEYAN NOUBAR | KANIA EDWIN M JR; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2015-07-14: Reporting owner NewcoGen Group, Inc. | Flagship Ventures Management, Inc. | AGTC Partners, L.P. | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | AGTC ADVISORS FUND LP | Applied Genomic Technology Capital Fund LP | AFEYAN NOUBAR | KANIA EDWIN M JR; Form 4; Security Series A Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2015-07-14: Reporting owner NewcoGen Group, Inc. | Flagship Ventures Management, Inc. | AGTC Partners, L.P. | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | AGTC ADVISORS FUND LP | Applied Genomic Technology Capital Fund LP | AFEYAN NOUBAR | KANIA EDWIN M JR; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-07-16 holding as of filing | Flagship Ventures 2007 General Partner LLC | Flagship Ventures Fund 2007, L.P. 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · Held by Flagship Ventures Fund 2007, L.P. | Holding | no price filed | 2015-07-16 | ||
| 2015-07-14 | NewcoGen Group, Inc. | Flagship Ventures Management, Inc. | AGTC Partners, L.P. | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | AGTC ADVISORS FUND LP | Applied Genomic Technology Capital Fund LP | AFEYAN NOUBAR | KANIA EDWIN M JR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · Held by Applied Genomic Technology Capital Fund, L.P. | C Conversion of derivative security | +13,553 13,553 owned after | $0.00 | 2015-07-16 | |
| 2015-07-14 | NewcoGen Group, Inc. | Flagship Ventures Management, Inc. | AGTC Partners, L.P. | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | AGTC ADVISORS FUND LP | Applied Genomic Technology Capital Fund LP | AFEYAN NOUBAR | KANIA EDWIN M JR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · Held by Applied Genomic Technology Capital Fund, L.P. | P Open market or private purchase of non-derivative or derivative security | +53,465 67,018 owned after | $1.70 | 2015-07-16 | |
| 2015-07-14 | NewcoGen Group, Inc. | Flagship Ventures Management, Inc. | AGTC Partners, L.P. | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | AGTC ADVISORS FUND LP | Applied Genomic Technology Capital Fund LP | AFEYAN NOUBAR | KANIA EDWIN M JR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · Held by AGTC Advisors Fund, L.P. | C Conversion of derivative security | $0.00 | 2015-07-16 | ||
| 2015-07-14 | NewcoGen Group, Inc. | Flagship Ventures Management, Inc. | AGTC Partners, L.P. | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | AGTC ADVISORS FUND LP | Applied Genomic Technology Capital Fund LP | AFEYAN NOUBAR | KANIA EDWIN M JR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · Held by AGTC Advisors Fund, L.P. | P Open market or private purchase of non-derivative or derivative security | $1.70 | 2015-07-16 | ||
| 2015-07-14 | NewcoGen Group, Inc. | Flagship Ventures Management, Inc. | AGTC Partners, L.P. | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | AGTC ADVISORS FUND LP | Applied Genomic Technology Capital Fund LP | AFEYAN NOUBAR | KANIA EDWIN M JR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · Held by Flagship Ventures Fund 2007, L.P. | C Conversion of derivative security | $0.00 | 2015-07-16 | ||
| 2015-07-14 | NewcoGen Group, Inc. | Flagship Ventures Management, Inc. | AGTC Partners, L.P. | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | AGTC ADVISORS FUND LP | Applied Genomic Technology Capital Fund LP | AFEYAN NOUBAR | KANIA EDWIN M JR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · Held by Flagship Ventures Fund 2007, L.P. | P Open market or private purchase of non-derivative or derivative security | $1.70 | 2015-07-16 | ||
| 2011-02-09 | Gilde Agribusiness Management B.V. | van der Meer Pieter | Perret Marc Olivier | de Graaf Edwin | Gilde Europe Food & Agribusiness Partners II C.V. | Gilde Europe Food & Agribusiness Fund B.V. | Gilde Healthcare Holding B.V. 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Gilde Europe Food & Agribusiness Fund B.V. | C Conversion of derivative security | −4,711,820 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | Gilde Agribusiness Management B.V. | van der Meer Pieter | Perret Marc Olivier | de Graaf Edwin | Gilde Europe Food & Agribusiness Partners II C.V. | Gilde Europe Food & Agribusiness Fund B.V. | Gilde Healthcare Holding B.V. 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By Gilde Europe Food & Agribusiness Fund B.V. | C Conversion of derivative security | −366,809 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | Applied Genomic Technology Capital Fund LP | AGTC Partners, L.P. | AGTC ADVISORS FUND LP 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By AGTC Advisors Fund, L.P. | C Conversion of derivative security | −366,933 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | Applied Genomic Technology Capital Fund LP | AGTC Partners, L.P. | AGTC ADVISORS FUND LP 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Applied Genomic Technology Capital Fund, L.P. | C Conversion of derivative security | −6,070,468 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | Applied Genomic Technology Capital Fund LP | AGTC Partners, L.P. | AGTC ADVISORS FUND LP 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By AGTC Advisors Fund, L.P. | C Conversion of derivative security | −38,083 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | Applied Genomic Technology Capital Fund LP | AGTC Partners, L.P. | AGTC ADVISORS FUND LP 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By Applied Genomic Technology Capital Fund, L.P. | C Conversion of derivative security | −630,026 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By NewcoGen Equity Investors LLC | C Conversion of derivative security | −1,323,360 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By NewcoGen-Elan LLC | C Conversion of derivative security | −798,046 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By NewcoGen-Long Reign Holding LLC | C Conversion of derivative security | −192,118 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By NewcoGen-PE LLC | C Conversion of derivative security | −799,747 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By ST NewcoGen LLC | C Conversion of derivative security | −191,692 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By AGTC Advisors Fund, L.P. | C Conversion of derivative security | −366,933 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Applied Genomic Technology Capital Fund, L.P. | C Conversion of derivative security | −6,070,468 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By OneLiberty Advisors Fund 2000 L.P. | C Conversion of derivative security | −15,097 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By OneLiberty Ventures 2000 L.P. | C Conversion of derivative security | −286,854 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By NewcoGen Equity Investors LLC | C Conversion of derivative security | −66,462 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By NewcoGen-Long Reign Holding LLC | C Conversion of derivative security | −9,432 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By NewcoGen-PE LLC | C Conversion of derivative security | −28,641 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By ST NewcoGen LLC | C Conversion of derivative security | −9,405 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By AGTC Advisors Fund, L.P. | C Conversion of derivative security | −38,083 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | NewcoGen PE LLC | Flagship Ventures Management, Inc. | AFEYAN NOUBAR | NewcoGen Long Reign Holding LLC | NewcoGen Group, Inc. | NEWCOGEN GROUP LLC | NEWCOGEN EQUITY INVESTORS LLC | ST NewcoGen LLC | KANIA EDWIN M JR | NewcoGen Elan LLC 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By Applied Genomic Technology Capital Fund, L.P. | C Conversion of derivative security | −630,026 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | Muntendam Pieter Director, Officer (President, CEO) | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −34,529 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | PAPADOPOULOS STELIOS Director | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,032,902 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-09 | PAPADOPOULOS STELIOS Director | 4 | Series D Preferred Stock Derivative · Direct | C Conversion of derivative security | −80,393 0 owned after | no price filed | 2011-02-11 | |
| 2011-02-03 holding as of filing | AGTC ADVISORS FUND LP | AGTC Partners, L.P. | Applied Genomic Technology Capital Fund LP 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2011-02-03 | ||
| 2011-02-03 holding as of filing | AGTC ADVISORS FUND LP | AGTC Partners, L.P. | Applied Genomic Technology Capital Fund LP 10% Owner | 10% Owner | 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2011-02-03 | ||
| 2011-02-03 holding as of filing | NewcoGen Elan LLC | ST NewcoGen LLC | NEWCOGEN GROUP LLC | NewcoGen Group, Inc. | KANIA EDWIN M JR | AFEYAN NOUBAR | NewcoGen PE LLC | Flagship Ventures Management, Inc. | NEWCOGEN EQUITY INVESTORS LLC | NewcoGen Long Reign Holding LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2011-02-03 | ||
| 2011-02-03 holding as of filing | NewcoGen Elan LLC | ST NewcoGen LLC | NEWCOGEN GROUP LLC | NewcoGen Group, Inc. | KANIA EDWIN M JR | AFEYAN NOUBAR | NewcoGen PE LLC | Flagship Ventures Management, Inc. | NEWCOGEN EQUITY INVESTORS LLC | NewcoGen Long Reign Holding LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2011-02-03 | ||
| 2011-02-03 holding as of filing | de Graaf Edwin | Gilde Agribusiness Management B.V. | Gilde Healthcare Holding B.V. | Gilde Europe Food & Agribusiness Fund B.V. | Perret Marc Olivier | van der Meer Pieter | Gilde Europe Food & Agribusiness Partners II C.V. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2011-02-03 | ||
| 2011-02-03 holding as of filing | de Graaf Edwin | Gilde Agribusiness Management B.V. | Gilde Healthcare Holding B.V. | Gilde Europe Food & Agribusiness Fund B.V. | Perret Marc Olivier | van der Meer Pieter | Gilde Europe Food & Agribusiness Partners II C.V. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2011-02-03 | ||
| 2011-02-03 holding as of filing | PAPADOPOULOS STELIOS Director | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2011-02-03 | ||
| 2011-02-03 holding as of filing | PAPADOPOULOS STELIOS Director | 3 | Series D Preferred Stock Derivative · Direct | Holding | no price filed | 2011-02-03 | ||
| 2011-02-03 holding as of filing | Muntendam Pieter Director, Officer (President, CEO) | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2011-02-03 |